In case you missed it: July 19 to July 23
It's been a busy week for the Contemporary OB/GYN® team.
This week's top articles included:
Risk of miscarriage with amniocentesis
Despite the inadvisability of performing early amniocentesis (EA) before 15 gestational weeks due to a high rate of miscarriage, a retrospective cohort study has found no significant difference in the procedure-related risk of miscarriage between EA, at around 14 weeks gestation, and mid-trimester amniocentesis (MA).
NIPT may not be as effective for twin pregnancies
Clinicians should carefully consider using noninvasive prenatal testing (NIPT) for the screening of chromosomal abnormalities in twin pregnancies because the combined positive predictive value (PPV) is limited and the screening efficiency is not stable, according to a prospective study.
Use of women's preventive health services during COVID-19
All categories of women’s preventive health services that required an in-person visit plummeted during the spring of 2020 due to the COVID-19 pandemic, in comparison to 2019, but then rebounded to near 2019 levels by July 2020.
Risk factors determine need for fetal echocardiogram in IVF pregnancies
In vitro fertilization (IVF) pregnancies only need fetal echocardiogram monitoring if other risk factors are present, according to a recent study.
Neurodevelopment outcomes of extremely preterm births
As more extremely preterm infants survive delivery, a study examines whether the advances that allowed for that survival also improve neurodevelopmental outcomes.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
